Long-term results of large prospective trials in childhood acute lymphoblastic leukemia


Much progress has been made in the biological characterization of acute lymphoblastic leukemia (ALL). Many biologic features with prognostic significance have been used together with clinical factors to define patient groups for risk-adapted therapy. However, it is well recognized that the prognostic significance of virtually all variables depends on the… (More)
DOI: 10.1038/sj.leu.2401977

2 Figures and Tables


  • Presentations referencing similar topics